Comprehensive preclinical evaluation of second-generation miRNA-regulated Coxsackievirus B3-BHP: Potent antitumor efficacy and safety
Molecular Therapy: Oncology
· Elsevier
Аннотация
Publication date: 17 September 2026 Source: Molecular Therapy Oncology, Volume 34, Issue 3 Author(s): Yuki Sakashita, Shohei Miyamoto, Miyako Sagara, Shun Ito, Yukiko Kobayashi, Yoshio Momoda, Fumiaki Yano, Ken Eto, Kenzaburo Tani, Mutsunori Murahashi
Читать у издателя →
Цитирование
Comprehensive preclinical evaluation of second-generation miRNA-regulated Coxsackievirus B3-BHP: Potent antitumor efficacy and safety. // Molecular Therapy: Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2950329926002080?dgcid=rss_sd_all
Comprehensive preclinical evaluation of second-generation miRNA-regulated Coxsackievirus B3-BHP: Potent antitumor efficacy and safety. Molecular Therapy: Oncology. https://www.sciencedirect.com/science/article/pii/S2950329926002080?dgcid=rss_sd_all
“Comprehensive preclinical evaluation of second-generation miRNA-regulated Coxsackievirus B3-BHP: Potent antitumor efficacy and safety.” Molecular Therapy: Oncology.
@article{article59426,
title = {Comprehensive preclinical evaluation of second-generation miRNA-regulated Coxsackievirus B3-BHP: Potent antitumor efficacy and safety},
journal = {Molecular Therapy: Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2950329926002080?dgcid=rss_sd_all}
}